Dr. Daniel Mark Skotte Sr., DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 56056 Beaver Drive, Sunriver, OR 97707 Phone: 541-593-5400 Fax: 541-593-4076 |
News Archive
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge, and the AstraZeneca IMED Biotech Unit reveals new insights into how the PTEN gene may control cell growth and behavior and how its loss contributes to the development and advancement of certain cancers.
Ten-year follow-up results of the U.S. Investigational Device Exemption Trial of the Melody transcatheter pulmonary valve were presented today during the SCAI 2020 Scientific Sessions Virtual Conference.
Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced the oral presentation of new data on its Smac mimetic drug candidate TL32711 at the 53rd ASH Annual Meeting and Exposition in San Diego.
According to PKD International, 12.5 million people are affected by polycystic kidney disease. There is no known cure. But that may one day change, thanks in part to new research by a Concordia biology researcher.
› Verified 4 days ago